Literature DB >> 24981411

[Microscopic extensions of head and neck squamous cell carcinomas: impact for clinical target volume definition].

B Fleury1, J Thariat2, R Barnoud3, G Buiret4, F Lebreton3, B Bancel3, M Poupart5, M Devouassoux-Shisheboran3.   

Abstract

PURPOSE: To assess microscopic extensions of head and neck squamous cell carcinomas aiming at a proposal for target volumes of radiation therapy.
MATERIALS AND METHODS: Surgical specimens were prospectively analysed macroscopically and microscopically. Tumour borders were identified per macroscopic visual examination and inked on stained slides. Then microscopic implants (perineural or lymphatic involvement, or in situ carcinomas) were looked for with an optic microscope in the macroscopic healthy tissue surrounding the tumour. The maximal length from tumour border was correlated with the maximal length of macroscopically healthy tissues assessable.
RESULTS: Twenty-one specimens were analysed and 12 were locally advanced tumours. Mean and median maximal microscopic extensions were 2.9 and 1.0mm (0-15mm), respectively. The 90th and 95th percentiles were 5 and 11mm, respectively. The ratio between healthy tissue length and maximal microscopic tumour extension was 10%. No correlation was found with tumour grade or volume.
CONCLUSION: The presence of microscopic tumour was unlikely after 5mm from macroscopic tumour (≤5% of patients in this series) but should be assessed along with other histoclinical factors and particularities of tumour behaviour by anatomic site. A rigorous terminology should authorize a relevant appreciation of local risk of recurrence, particularly in adjuvant setting or for clinical target volume definition. Larger and more homogenous confirmatory series are needed.
Copyright © 2014. Published by Elsevier SAS.

Entities:  

Keywords:  Carcinome épidermoïde ORL; Conformal radiotherapy; Head and neck squamous cell carcinomas; Histology; Radiothérapie conformationnelle; Target volumes; Volume cible

Mesh:

Year:  2014        PMID: 24981411     DOI: 10.1016/j.canrad.2014.04.006

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin.

Authors:  Hans Ligtenberg; Stefan M Willems; Lilian N Ruiter; Elise Anne Jager; Chris H J Terhaard; Cornelis P J Raaijmakers; Marielle E P Philippens
Journal:  Clin Transl Radiat Oncol       Date:  2018-07-11

2.  Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma.

Authors:  C Bondue; S Racadot; A Coutte; P Dupuis; M C Biston; V Grégoire
Journal:  Clin Transl Radiat Oncol       Date:  2019-06-20

3.  Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?

Authors:  Mark T Corkum; Sylvia Mitchell; Varagur Venkatesan; Nancy Read; Andrew Warner; David A Palma
Journal:  Adv Radiat Oncol       Date:  2019-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.